141 related articles for article (PubMed ID: 1429553)
1. Down-regulation of interleukin 6 receptors of mouse myelomonocytic leukemic cells by leukemia inhibitory factor.
Yamaguchi M; Michishita M; Hirayoshi K; Yasukawa K; Okuma M; Nagata K
J Biol Chem; 1992 Nov; 267(31):22035-42. PubMed ID: 1429553
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M is a differentiation factor for myeloid leukemia cells.
Bruce AG; Hoggatt IH; Rose TM
J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
[TBL] [Abstract][Full Text] [Related]
3. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
4. Leukemia inhibitory factor, interleukin-6, and their receptors are expressed transiently in the olfactory mucosa after target ablation.
Nan B; Getchell ML; Partin JV; Getchell TV
J Comp Neurol; 2001 Jun; 435(1):60-77. PubMed ID: 11370011
[TBL] [Abstract][Full Text] [Related]
5. Expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha, and gp130) in human peripheral neuropathies.
Ito Y; Yamamoto M; Mitsuma N; Li M; Hattori N; Sobue G
Neurochem Res; 2001 Jan; 26(1):51-8. PubMed ID: 11358282
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6-type cytokines and their receptors for gene therapy of melanoma.
Mackiewicz A; Wiznerowicz M; Roeb E; Nowak J; Pawlowski T; Baumann H; Heinrich PC; Rose-John S
Ann N Y Acad Sci; 1995 Jul; 762():361-73; discussion 373-4. PubMed ID: 7668537
[TBL] [Abstract][Full Text] [Related]
7. Expression of leukemia inhibitory factor (LIF)/interleukin-6 family cytokines and receptors during in vitro osteogenesis: differential regulation by dexamethasone and LIF.
Liu F; Aubin JE; Malaval L
Bone; 2002 Jul; 31(1):212-9. PubMed ID: 12110437
[TBL] [Abstract][Full Text] [Related]
8. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
Palmqvist P; Persson E; Conaway HH; Lerner UH
J Immunol; 2002 Sep; 169(6):3353-62. PubMed ID: 12218157
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor.
Gearing DP; Bruce AG
New Biol; 1992 Jan; 4(1):61-5. PubMed ID: 1536831
[TBL] [Abstract][Full Text] [Related]
10. A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor.
Layton MJ; Cross BA; Metcalf D; Ward LD; Simpson RJ; Nicola NA
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8616-20. PubMed ID: 1528870
[TBL] [Abstract][Full Text] [Related]
11. High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution.
Godard A; Heymann D; Raher S; Anegon I; Peyrat MA; Le Mauff B; Mouray E; Gregoire M; Virdee K; Soulillou JP
J Biol Chem; 1992 Feb; 267(5):3214-22. PubMed ID: 1737777
[TBL] [Abstract][Full Text] [Related]
12. Induction of differentiation of WEHI-3B D+ leukemic cells transfected with differentiation-stimulating factor/leukemia inhibitory factor receptor cDNA.
Tomida M
Blood; 1995 Jan; 85(1):217-21. PubMed ID: 7528568
[TBL] [Abstract][Full Text] [Related]
13. Kinetic analyses of the binding of leukemia inhibitory factor to receptor on cells and membranes and in detergent solution.
Hilton DJ; Nicola NA
J Biol Chem; 1992 May; 267(15):10238-47. PubMed ID: 1587813
[TBL] [Abstract][Full Text] [Related]
14. [Function, molecular structure and gene expression regulation of receptor for D-factor/LIF].
Tomida M
Nihon Rinsho; 1992 Aug; 50(8):1956-61. PubMed ID: 1433987
[TBL] [Abstract][Full Text] [Related]
15. Regulation of signal transducer, GP13O and the LIF receptor in acute inflammation in vivo.
Geisterfer M; Gauldie J
Cytokine; 1996 Apr; 8(4):283-7. PubMed ID: 9162216
[TBL] [Abstract][Full Text] [Related]
16. Differential temporal expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha and gp130) in injured peripheral nerves.
Ito Y; Yamamoto M; Li M; Doyu M; Tanaka F; Mutch T; Mitsuma T; Sobue G
Brain Res; 1998 May; 793(1-2):321-7. PubMed ID: 9630704
[TBL] [Abstract][Full Text] [Related]
17. Expression of interleukin (IL)-11 receptor by the human endometrium in vivo and effects of IL-11, IL-6 and LIF on the production of MMP and cytokines by human endometrial cells in vitro.
Cork BA; Tuckerman EM; Li TC; Laird SM
Mol Hum Reprod; 2002 Sep; 8(9):841-8. PubMed ID: 12200462
[TBL] [Abstract][Full Text] [Related]
18. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
[TBL] [Abstract][Full Text] [Related]
19. Analysis of recombinant soluble mouse D-factor/LIF receptor.
Tomida M
J Biochem; 1995 Jun; 117(6):1228-31. PubMed ID: 7490264
[TBL] [Abstract][Full Text] [Related]
20. Leukemia inhibitory factor antagonizes gonadotropin induced-testosterone synthesis in cultured porcine leydig cells: sites of action.
Mauduit C; Goddard I; Besset V; Tabone E; Rey C; Gasnier F; Dacheux F; Benahmed M
Endocrinology; 2001 Jun; 142(6):2509-20. PubMed ID: 11356700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
